Activation of RyR2 by class I kinase inhibitors
- Autores
- Chakraborty, A. D.; Gonano, Luis Alberto; Munro, M. L.; Smith, L. J,; Thekkedam, C.; Staudacher, V.; Gamble, A. B.; Macquaide, N.; Dulhunty, A. F.; Jones, P. P.
- Año de publicación
- 2019
- Idioma
- español castellano
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Kinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds.
Centro de Investigaciones Cardiovasculares - Materia
- Ciencias Médicas
- Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by-nc-sa/4.0/
- Repositorio
- Institución
- Universidad Nacional de La Plata
- OAI Identificador
- oai:sedici.unlp.edu.ar:10915/108114
Ver los metadatos del registro completo
id |
SEDICI_b21994f18d8d11781c227974983b851d |
---|---|
oai_identifier_str |
oai:sedici.unlp.edu.ar:10915/108114 |
network_acronym_str |
SEDICI |
repository_id_str |
1329 |
network_name_str |
SEDICI (UNLP) |
spelling |
Activation of RyR2 by class I kinase inhibitorsChakraborty, A. D.Gonano, Luis AlbertoMunro, M. L.Smith, L. J,Thekkedam, C.Staudacher, V.Gamble, A. B.Macquaide, N.Dulhunty, A. F.Jones, P. P.Ciencias MédicasKinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds.Centro de Investigaciones Cardiovasculares2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf773-786http://sedici.unlp.edu.ar/handle/10915/108114spainfo:eu-repo/semantics/altIdentifier/url/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6393232&blobtype=pdfinfo:eu-repo/semantics/altIdentifier/issn/0007-1188info:eu-repo/semantics/altIdentifier/pmid/30588601info:eu-repo/semantics/altIdentifier/doi/10.1111/bph.14562info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-10-15T11:15:46Zoai:sedici.unlp.edu.ar:10915/108114Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-10-15 11:15:46.926SEDICI (UNLP) - Universidad Nacional de La Platafalse |
dc.title.none.fl_str_mv |
Activation of RyR2 by class I kinase inhibitors |
title |
Activation of RyR2 by class I kinase inhibitors |
spellingShingle |
Activation of RyR2 by class I kinase inhibitors Chakraborty, A. D. Ciencias Médicas |
title_short |
Activation of RyR2 by class I kinase inhibitors |
title_full |
Activation of RyR2 by class I kinase inhibitors |
title_fullStr |
Activation of RyR2 by class I kinase inhibitors |
title_full_unstemmed |
Activation of RyR2 by class I kinase inhibitors |
title_sort |
Activation of RyR2 by class I kinase inhibitors |
dc.creator.none.fl_str_mv |
Chakraborty, A. D. Gonano, Luis Alberto Munro, M. L. Smith, L. J, Thekkedam, C. Staudacher, V. Gamble, A. B. Macquaide, N. Dulhunty, A. F. Jones, P. P. |
author |
Chakraborty, A. D. |
author_facet |
Chakraborty, A. D. Gonano, Luis Alberto Munro, M. L. Smith, L. J, Thekkedam, C. Staudacher, V. Gamble, A. B. Macquaide, N. Dulhunty, A. F. Jones, P. P. |
author_role |
author |
author2 |
Gonano, Luis Alberto Munro, M. L. Smith, L. J, Thekkedam, C. Staudacher, V. Gamble, A. B. Macquaide, N. Dulhunty, A. F. Jones, P. P. |
author2_role |
author author author author author author author author author |
dc.subject.none.fl_str_mv |
Ciencias Médicas |
topic |
Ciencias Médicas |
dc.description.none.fl_txt_mv |
Kinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds. Centro de Investigaciones Cardiovasculares |
description |
Kinase inhibitors are a common treatment for cancer. Class I kinase inhibitors that target the ATP-binding pocket are particularly prevalent. Many of these compounds are cardiotoxic and can cause arrhythmias. Spontaneous release of Ca2+ via cardiac ryanodine receptors (RyR2), through a process termed store overload-induced Ca2+ release (SOICR), is a common mechanism underlying arrhythmia. We explored whether class I kinase inhibitors could modify the activity of RyR2 and trigger SOICR to determine if this contributes to the cardiotoxic nature of these compounds. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Articulo http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://sedici.unlp.edu.ar/handle/10915/108114 |
url |
http://sedici.unlp.edu.ar/handle/10915/108114 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6393232&blobtype=pdf info:eu-repo/semantics/altIdentifier/issn/0007-1188 info:eu-repo/semantics/altIdentifier/pmid/30588601 info:eu-repo/semantics/altIdentifier/doi/10.1111/bph.14562 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
dc.format.none.fl_str_mv |
application/pdf 773-786 |
dc.source.none.fl_str_mv |
reponame:SEDICI (UNLP) instname:Universidad Nacional de La Plata instacron:UNLP |
reponame_str |
SEDICI (UNLP) |
collection |
SEDICI (UNLP) |
instname_str |
Universidad Nacional de La Plata |
instacron_str |
UNLP |
institution |
UNLP |
repository.name.fl_str_mv |
SEDICI (UNLP) - Universidad Nacional de La Plata |
repository.mail.fl_str_mv |
alira@sedici.unlp.edu.ar |
_version_ |
1846064215638409216 |
score |
13.22299 |